A cost-minimization analysis of oncology home care versus hospital care

被引:13
|
作者
Serrate, RS
Ferrer-Roca, O
González-Dávila, E
机构
[1] Delfos Clin, Oncol Serv, Barcelona, Spain
[2] Univ La Laguna, Fac Med, CATAI Telemed Grp, Tenerife, Spain
[3] Univ La Laguna, Dept Stat Invest Operat & Computac, Tenerife, Spain
关键词
D O I
10.1258/1357633011936444
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
We compared the costs of patient care for two groups of 10 oncology patients. The test group was treated at home and had access to 24 h telephone support, and the control group was treated in hospital, either as inpatients or as outpatients. Direct variable costs were provided by health insurance companies. The time invested by the health-care staff was recorded. The amount of time devoted to patients was more uniform in hospital than in the patients' homes, which suggests that patients at home received a less generic, more specific form of care. The nurses spent four times as long caring for home care patients as for hospital patients. The total cost of home care was 64% of that of hospital care, although this difference was not significant. The mean daily costs were three times lower at home than in hospital. All direct costs, except laboratory tests, were lower at home. Pharmaceutical costs were six times lower at home. Telephone support for home oncology care was cost saving and avoided 27 nursing home visits, which represented 35 working hours and Pta270,000 in savings to the health insurance companies.
引用
收藏
页码:226 / 232
页数:7
相关论文
共 50 条
  • [21] Treating patients with opioid overdose at a primary care emergency outpatient clinic: a cost-minimization analysis
    Jon Hjellum Vibeto
    Odd Martin Vallersnes
    Andrea Dobloug
    Mette Brekke
    Dag Jacobsen
    Øivind Ekeberg
    Knut Reidar Wangen
    Cost Effectiveness and Resource Allocation, 19
  • [22] A COST-MINIMIZATION ANALYSIS OF DERMATOPHYTE TEST KIT WITH ONYCHOMYCOSIS UNDER HEALTH CARE SYSTEM IN JAPAN
    Watanabe, R.
    Igarashi, A.
    Wakamoto, H.
    Osawa, H.
    VALUE IN HEALTH, 2016, 19 (07) : A690 - A690
  • [23] Treating patients with opioid overdose at a primary care emergency outpatient clinic: a cost-minimization analysis
    Vibeto, Jon H.
    Vallersnes, Odd Martin
    Dobloug, Andrea
    Brekke, Mette
    Jacobsen, Dag
    Ekeberg, Oivind
    Wangen, Knut Reidar
    CLINICAL TOXICOLOGY, 2020, 58 (06) : 566 - 567
  • [24] COST-MINIMIZATION ANALYSIS OF THE USE OF RASBURICASE IN TUMOR LYSIS SYNDROME IN PEDIATRIC ONCOLOGY
    Rodrigues, A. H.
    Follador, W.
    Abadi, M.
    Petrilli, A. S.
    VALUE IN HEALTH, 2011, 14 (03) : A166 - A166
  • [25] Cost-minimization of TIPS versus paracentesis in refractory ascites: A decision analysis
    Koss, MV
    Kulik, LM
    Wiley, TE
    Halline, AG
    GASTROENTEROLOGY, 2001, 120 (05) : A407 - A407
  • [26] Robot-Assisted Versus Open Sacrocolpopexy: A Cost-Minimization Analysis
    Elliott, Christopher S.
    Hsieh, Michael H.
    Sokol, Eric R.
    Comiter, Craig V.
    Payne, Christopher K.
    Chen, Bertha
    JOURNAL OF UROLOGY, 2012, 187 (02): : 638 - 643
  • [27] Cost-minimization analysis of piperacillin/tazobactam versus imipenem/cilastatin for the treatment of serious infections: A Canadian hospital perspective
    Marra, FO
    Frighetto, LO
    Marra, CA
    Sleigh, KM
    Stiver, HG
    Bryce, EA
    Reynolds, RP
    Jewesson, PJ
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (02) : 156 - 162
  • [28] PRELIMINARY COST-MINIMIZATION ANALYSIS OF CONTINUOUS VERSUS INTERMITTENT RENAL REPLACEMENT THERAPY IN INTENSIVE CARE PATIENTS EXPERIENCING ACUTE RENAL FAILURE
    Banz, K.
    Harenski, K.
    Brunner, M.
    von Czettritz, T.
    VALUE IN HEALTH, 2011, 14 (07) : A332 - A332
  • [29] A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit
    Dasta, Joseph F.
    Kane-Gill, Sandra L.
    Pencina, Michael
    Shehabi, Yahya
    Bokesch, Paula M.
    Wisernandle, Wayne
    Riker, Richard R.
    CRITICAL CARE MEDICINE, 2010, 38 (02) : 497 - 503
  • [30] COST-MINIMIZATION OF MABTHERA INTRAVENOUS VERSUS SUBCUTANEOUS ADMINISTRATION
    Bax, P.
    Postma, M. J.
    VALUE IN HEALTH, 2013, 16 (07) : A390 - A391